NYSE:SOLVMedical Equipment
Will Solventum's (SOLV) $1 Billion Buyback and Strong 2025 Earnings Redefine Its Capital Story?
In late February 2026, Solventum Corporation reported fourth-quarter 2025 revenue of US$1,998 million and full-year revenue of US$8,325 million, alongside a sharp increase in net income to US$1,556 million and detailed 2026 guidance for organic sales growth, earnings and free cash flow.
At the same time, the company announced a US$1.00 billion share repurchase program and reiterated its focus on portfolio optimization and tuck-in acquisitions, signaling a stronger emphasis on capital...